Rob Holgate

Rob Holgate has more than 20 years of experience in the field, with roles at Abzena, MedImmune (formerly Cambridge Antibody Technology), and the University of York. At Abzena, they currently hold the position of VP of Research & Innovation, where they manage client-sponsored research collaborations and the company's internal therapeutic antibody pipeline. Previously at MedImmune, they served as a Team Leader and Senior Scientist, gaining knowledge in antibodies and drug discovery. At the University of York, they worked as a Post Doctoral Researcher.

Rob Holgate completed their education with a Bachelor of Science degree in Biochemistry from King's College London in the years 1991-1995. Following this, they pursued a PhD in Molecular Genetics at UCL during 1995-1999.